COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Abstract

Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide concern. SARS-CoV-2 has spread to 210 countries worldwide and more than 6,500,000 confirmed cases and 384,643 deaths have been reported, while the number of both confirmed and fatal cases is continually increasing. COVID-19 is a viral disease that can affect every age group—from infants to the elderly—resulting in a wide spectrum of various clinical manifestations. COVID-19 might present different degrees of severity—from mild or even asymptomatic carriers, even to fatal cases. The most common complications include pneumonia and acute respiratory distress syndrome. Fever, dry cough, muscle weakness, and chest pain are the most prevalent and typical symptoms of COVID-19. However, patients might also present atypical symptoms that can occur alone, which might indicate the possible SARS-CoV-2 infection. The aim of this paper is to review and summarize all of the findings regarding clinical manifestations of COVID-19 patients, which include respiratory, neurological, olfactory and gustatory, gastrointestinal, ophthalmic, dermatological, cardiac, and rheumatologic manifestations, as well as specific symptoms in pediatric patients.

References 243

1. 1.

   World Health Organization (WHO). Statement on the Second Meeting of the International Health Regulations Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). 2005.

   Not in our library

2. 2.

   World Health Organisation. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11. 2020.

   Not in our library

3. 3.

   Setti L., Passarini F., De Gennaro G., Barbieri P., Pallavicini A., Ruscio M., Piscitelli P., Colao A., Miani A. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Int. J. Environ. Res. Public Health. 2020;17:2986.

   Not in our library10.3390/ijerph17092986

4. 4.

   Vincent J.-L., Taccone F.S. Understanding pathways to death in patients with COVID-19. Lancet Respir. Med. 2020;8:430-432.

   Not in our library10.1016/s2213-2600(20)30165-x

5. 5.

   Nadeem M., Zamzami M., Choudhry H., Murtaza B., Kazmi I., Ahmad H., Shakoori A. Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19). Pathogens. 2020;9:307.

   Not in our library10.3390/pathogens9040307

6. 6.

   Hui D.S., Wong P.-C., Wang C. SARS: Clinical features and diagnosis. Respirology. 2003;8:S20-S24.

   Not in our library10.1046/j.1440-1843.2003.00520.x

7. 7.
   MERS-CoV: Understanding the Latest Human Coronavirus Threat · 2018

   No notice
8. 8.

   Yang W., Cao Q., Qin L., Wang X., Cheng Z., Pan A., Dai J., Sun Q., Zhao F., Qu J.-M., et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J. Infect. 2020;80:388-393.

   Not in our library10.1016/j.jinf.2020.02.016

9. 9.

   Ooi G.C., Daqing M. SARS: Radiological features. Respirology. 2003;8:S15-S19.

   Not in our library10.1046/j.1440-1843.2003.00519.x

10. 10.

    Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2017;23:130-137.

    Not in our library10.1111/resp.13196

11. 11.

    Salehi S., Abedi A., Balakrishnan S., Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. Am. J. Roentgenol. 2020;1-7.

    Not in our library10.2214/ajr.20.23034

12. 12.

    Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 2020;20:425-434.

    Not in our library10.1016/s1473-3099(20)30086-4

13. 13.

    Meltzer M.I. Multiple Contact Dates and SARS Incubation Periods. Emerg. Infect. Dis. 2004;10:207-209.

    Not in our library10.3201/eid1002.030426

14. 14.

    Investigation of Cases of Human Infection with MERS-CoV [Internet]. 2018.

    Not in our library

15. 15.

    Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R., Azman A.S., Reich N.G., Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann. Intern. Med. 2020;172:577-582.

    Not in our library10.7326/m20-0504

16. 16.

    Ding Y., He L., Zhang Q., Huang Z., Che X.-Y., Hou J., Wang H., Shen H., Qiu L., Li Z., et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J. Pathol. 2004;203:622-630.

    Not in our library10.1002/path.1560

17. 17.

    Otter J., Donskey C., Yezli S., Douthwaite S., Goldenberg S.D., Weber D. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination. J. Hosp. Infect. 2016;92:235-250.

    Not in our library10.1016/j.jhin.2015.08.027

18. 18.

    Omrani A.S., Al-Tawfiq J.A., A Memish Z. Middle East respiratory syndrome coronavirus (MERS-CoV): Animal to human interaction. Pathog. Glob. Health. 2015;109:354-362.

    Not in our library10.1080/20477724.2015.1122852

19. 19.

    Perlman S., Mccray P.B. Person-to-Person Spread of the MERS Coronavirus—An Evolving Picture. N. Engl. J. Med. 2013;369:466-467.

    Not in our library10.1056/nejme1308724

20. 20.
    Airborne transmission of SARS-CoV-2: The world should face the reality · 2020

    Not checked
21. 21.
    Stability of SARS-CoV-2 in different environmental conditions · 2020

    No notice
22. 22.

    Chen Y., Chen L., Deng Q., Zhang G., Wu K., Ni L., Yang Y., Liu B., Wang W., Wei C., et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J. Med. Virol. 2020.

    Not in our library10.1002/jmv.25825

23. 23.

    Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. COVID-19, SARS and MERS: Are they closely related? Clin. Microbiol. Infect. 2020;26:729-734.

    Not in our library10.1016/j.cmi.2020.03.026

24. 24.

    Gandhi R.T., Lynch J.B., Del Rio C. Mild or Moderate Covid-19. N. Engl. J. Med. 2020.

    Not in our library10.1056/nejmcp2009249

25. 25.

    Fu L., Wang B., Yuan T., Chen X., Ao Y., Fitzpatrick T., Li P., Zhou Y., Lin Y.-F., Duan Q., et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J. Infect. 2020;80:656-665.

    Not in our library10.1016/j.jinf.2020.03.041

26. 26.

    Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368:m1091.

    Not in our library10.1136/bmj.m1091

27. 27.

    WHO. Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection Is Suspected.

    Not in our library

28. 28.

    Li J.-Y., You Z., Wang Q., Zhou Z.-J., Qiu Y., Luo R., Ge X.-Y. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22:80-85.

    Not in our library10.1016/j.micinf.2020.02.002

29. 29.
    The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control · 2020

    No notice
30. 30.

    Li L.-Q., Huang T., Wang Y.-Q., Wang Z.-P., Liang Y., Huang T.-B., Zhang H.-Y., Sun W.-M., Wang Y.-P. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J. Med. Virol. 2020;92:577-583.

    Not in our library10.1002/jmv.25757

31. 31.

    Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z.-Y. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J. Gen. Intern. Med. 2020;35:1545-1549.

    Not in our library10.1007/s11606-020-05762-w

32. 32.

    Nishiura H., Kobayashi T., Miyama T., Suzuki A., Jung S.-M., Hayashi K., Kinoshita R., Yang Y., Yuan B., Akhmetzhanov A.R., et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 2020;94:154-155.

    Not in our library10.1016/j.ijid.2020.03.020

33. 33.

    Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507-513.

    Not in our library10.1016/s0140-6736(20)30211-7

34. 34.
    The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020 · 2020

    No notice
35. 35.
    A Systematic Review of COVID-19 Epidemiology Based on Current Evidence · 2020

    No notice
36. 36.

    Lei S., Jiang F., Su W., Chen C., Chen J., Mei W., Zhan L.Y., Jia Y., Zhang L., Liu D., et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331.

    Not in our library10.1016/j.eclinm.2020.100331

37. 37.

    Guan W.-J., Ni Z.-Y., Hu Y., Liang W.-H., Ou C.-Q., He J.-X., Liu L., Shan H., Lei C.-L., Hui D.S., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708-1720.

    Not in our library10.1056/nejmoa2002032

38. 38.
    Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China · 2020

    No notice
39. 39.

    Wang Z., Chen X., Lu Y., Chen F., Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci. Trends. 2020;14:64-68.

    Not in our library10.5582/bst.2020.01030

40. 40.

    Kim E.S., Chin B.S., Kang C.K., Kim N.J., Kang Y.M., Choi J.-P., Oh D.H., Kim J.-H., Koh B., Kim S.E., et al. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J. Korean Med. Sci. 2020;35:e142.

    Not in our library10.3346/jkms.2020.35.e142

Cited by papers we hold 4

• Cannabinoids: Therapeutic Use in Clinical Practice · 2022
  No notice
• Genetics Insight for COVID-19 Susceptibility and Severity: A Review · 2021
  No notice
• COVID-19 and Its Symptoms’ Panoply: A Case-Control Study of 919 Suspected Cases in Locked-Down Ovar, Portugal · 2021
  Not checked
• Novel respiratory infectious diseases in Korea · 2020
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.